Ukraine

 

Will record results for Synlab precipitate Cinven sale?

Almost a year after its IPO, lab giant Synlab has posted strong FY21 results bolstered by Covid, but not, it says, dependant on it. Management say extra cash will be used as a springboard for growth. Could it also lead to private equity majority shareholder Cinven selling its remaining interest?

Sector reacts to invasion on Ukraine

How are for-profit health care groups being affected by and reacting to the Russian invasion of Ukraine? Some are providing free services to refugees, others are supporting Ukrainian armed forces. HBI speaks to Michał Rybak, CFO at Lux Med, leading Polish for-profit operator and Konstantin Lebediev, an expert on private healthcare in Ukraine and a former General Manager of the first private hospital in Central and Eastern Europe (CEE).

Ukrainian operators calm, but foreign investment could falter

The eyes of the world have been on Ukraine recently, as the risk of a Russian invasion ramps up. HBI speaks to operators, private equity, and pharma in the region to see if nerves are being held, or fraying, and how what happens in the next few weeks might hit for-profit healthcare in the region.

Horizon exits Dobrobut two years in with Boris merger done

Horizon Capital has sold its minority stake in Ukrainian clinic network Dobrobut to management and co-investor Concorde Capital, just two years after investing. Dobrobut's merger with hospital Boris Clinic, which was ongoing when Horizon invested, is now complete. 

CEE – a land of opportunity?

With 125 million people - 80 million of whom live in the big four (Poland, Romania, Czechia and Hungary) - CEE is a large and diverse market. But is it a tempting one? HBI-365 members heard an expert panel in our CEE State of the Regions broadcast suggest that while COVID is creating huge problems across the world, it is also creating opportunities in Central and Eastern Europe.

Operators in Russia and ex-CIS hit hard by COVID

State financing has seen little growth in expenditure in Russia over the last couple of years, while former CIS countries are struggling to fund robust healthcare systems. Despite this, panellists at HBI's Russia and Former CIS - State of the Regions discussion last week found some reasons to be positive.

Occupational healthcare “cuts cost of absenteeism by half”

The COVID-19 pandemic shifted the working patterns and environments of every type of workforce, resulting in big hits to free-for-service (FFS) business models and new opportunities in remote care. Panellists from Medicover, Medigold and Qualitas discussed this and how good occupational healthcare can reduce the costs of absenteeism by half, at last week's HBI Big Picture Seminar.

Interview: Arjan Toor, CEO, Cigna Europe

Cigna now describes itself as “a global health service company” rather than an insurer and has reorganised its European operations. Toor has recently been promoted to CEO Europe. He says that the insurer, which has 15% (US$840m) of its revenue in Europe, doesn't want to verticalise through owning primary care providers but wants instead to provide an end-to-end user experience.

Find Us